מונטהלוקאסט אינובמד 5 מ"ג

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

MONTELUKAST AS SODIUM 5 MG

Доступно од:

INOVAMED LTD

АТЦ код:

R03DC03

Фармацеутски облик:

CHEWABLE TABLETS

Пут администрације:

PER OS

Произведен од:

SYNTHON B.V., NETHERLANDS

Терапеутска група:

MONTELUKAST

Терапеутске индикације:

Montelukast Inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.

Датум одобрења:

2012-01-01